Published May 27, 2023



PLUMX
Google Scholar
 
Search GoogleScholar


Amadou B. Diarra*

Moussa Cisse

N’Falaye Kamissoko

Rokia Tangara

Gaoussou Togora

Sekou O Coulibaly

Adama Traoré

Sory I. Diawara

Article Details

Abstract

Transfusion is an essential therapeutic act for the management of many situations in medicine, but it is not without risks and carries high risks of transmission of viral, parasitic and bacterial infections. In order to develop strategies to improve blood safety in Mali, we conducted a retrospective study of 4037 blood donors at the National Blood Transfusion Center (CNTS) in Bamako from September to November 2021. The aim of the study was to determine HIV/AIDS co-infection in blood donors. The search for serological infection markers was carried out by chemiluminescence for the detection of HIV and Syphilis. The device used was the Architecte Plus i1000. The seroprevalence of syphilis was 0.9% (36/4037), while that of HIV was 0.8% (31/4037). HIV/Syphilis co-infection represented 0.4% (17/4037). We conclude that the seroprevalence of HIV/Syphilis co-infection is low at the CNTS in Bamako, however the risk of threat to transfusion safety exists. Therefore, it is imperative to consolidate the achievements and to strengthen the screening capacity for these blood-borne infections in order to ensure optimal blood safety.

Keywords
References
1. Tagny CT. Le dépistage biologique de la syphilis chez le donneur de sang d’Afrique subsaharienne : quelle stratégie ? Transfusion Clinique et Biologique. nov 2009;16(5‑6):448‑53.
2. WHO. Prevention and control of viral hepatitis: framework for global action 2012. 2012 [cité 30 sept 2016]; Disponible sur: www.who.int (csr) disease/heptatitis/GHP framwork
3. Weimer A, Tagny CT, Tapko JB, Gouws C, Tobian AAR, Ness PM, et al. Blood transfusion safety in sub‐Saharan Africa: A literature review of changes and challenges in the 21st century. Transfusion. janv 2019;59(1):412‑27.
4. Tayou CT, Kouao MD, Touré H, Gargouri J, Fazul AS, Ouattara S, et al. Transfusion safety in francophone African countries: an analysis of strategies for the medical selection of blood donors. Transfusion. janv 2012;52(1):134‑43.
5. Lefrère JJ, Dahourouh H, Dokekias AE, Kouao MD, Diarra A, Diop S, et al. Estimate of the residual risk of transfusion-transmitted human immunodeficiency virus infection in sub-Saharan Africa: a multinational collaborative study: HIV BLOOD TRANSFUSION RISK IN AFRICA. Transfusion. Mars 2011; 51(3):486‑92.
6. Tagny CT, Diarra A, Yahaya R, Hakizimana M, Nguessan A, Mbensa G, et al. Characteristics of blood donors and donated blood in sub-Saharan Francophone Africa. Transfusion. août 2009;49(8):1592‑9.
7. Diarra A, Kouriba B, Baby M, Murphy E, Lefrere JJ. HIV, HCV, HBV and syphilis rate of positive donations among blood donations in Mali: Lower rates among volunteer blood donors. Transfusion Clinique et Biologique. 1 nov 2009; 16(5):444‑7.
8. Baby M, Fongoro S, Konaté MK, Diarra A, Kouriba B, Maïga MK. [Prevalence and risk factors of hepatitis C virus infection in chronic hemodialysis patients at the University Hospital of Point G, Bamako, Mali]. Mali Med. 2011; 26(2):12‑5.
9. Traore H, Guitteye H, Sangho O, Diarra AB, Cissé M, Ba A, et al. Etude comparative de la séroprévalence des infections au VIH, VHB ET VHC chez les donneurs de sang en collecte fixe et mobile. Rev Mali Infectiol Microbiol. 4 déc 2019;14(2):52‑7.
10. Diarra AB, Guitteye H, Fomba M, Cissé M, Traore D, Traore A, et al. Les hépatites virales B et C chez les donneurs de sang du centre national de transfusion sanguine de Bamako, Mali. Rev Mali Infectiol Microbiol. 4 déc 2019;14(2):58‑61.
11. Nébié KY, Olinger CM, Kafando E, Dahourou H, Diallo S, Kientega Y, et al. Faible niveau de connaissances des donneurs de sang au Burkina Faso ; une entrave potentielle à la sécurité transfusionnelle. Transfusion Clinique et Biologique. nov 2007;14(5):446‑52.
12. Jary A, Dienta S, Leducq V, Le Hingrat Q, Cisse M, Diarra AB, et al. Seroprevalence and risk factors for HIV, HCV, HBV and syphilis among blood donors in Mali. BMC Infect Dis. déc 2019; 19(1):1064.
13. Sarigül F, Sayan M, İnan D, Deveci A, Ceran N, Çelen MK, et al. Current status of HIV/AIDS-syphilis co-infections: a retrospective multicentre study. Cent Eur J Public Health. 30 sept 2019; 27(3):223‑8.
14. Stevenson J, Heath M. Syphilis and HIV Infection: an Update. Dermatologic Clinics. oct 2006;24(4):497‑507.
15. Grillo M, Tran BR, Tamoufe U, Djoko CF, Saylors K, Woodland K, et al. HIV and Syphilis Prevalence and Associated Risks in the Cameroonian Armed Forces. CHR [Internet]. 15 juin 2017 [cité 4 mai 2023]:15 (2). Disponible sur: http://www. Eurekaselect. com/152487/article
16. Weng RX, Hong FC, Yu WY, Cai YM. Compare HIV/syphilis infections between age groups and explore associated factors of HIV/syphilis co-infections among men who have sex with men in Shenzhen, China, from 2009 to 2017. Wang Z, éditeur. PLoS ONE. 3 oct 2019; 14(10):e0223377.
Section
Original Article